Guislaine Barrière
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 1
- Oncology top 10%
- Cancer Cells and Metastasis 6
- Cancer Diagnosis and Treatment 2
-
- Metastasis and carcinoma case studies 4
-
- Cell death mechanisms and regulation 1
- Hedgehog Signaling Pathway Studies 1
-
- Selenium in Biological Systems 1
-
- Estrogen and related hormone effects 1
- Co-authors
- Michel RigaudPietro FiciGiulia GalleraniFrancesco� FabbriWainer ZoliJeanne Cook‐MoreauKarine FaucherFranck Sturtz
- Partner nations
- FranceItalyUnited Kingdom
In The Last Decade
Guislaine Barrière
12 papers receiving 527 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 211
- Oncology 301
- Pulmonary and Respiratory Medicine 102
- Molecular Biology 193
- Biological Psychiatry 6
Countries citing papers authored by Guislaine Barrière
This map shows the geographic impact of Guislaine Barrière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guislaine Barrière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guislaine Barrière more than expected).
Fields of papers citing papers by Guislaine Barrière
This network shows the impact of papers produced by Guislaine Barrière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guislaine Barrière. The network helps show where Guislaine Barrière may publish in the future.
Co-authorship network
The 12 scholars most cited alongside Guislaine Barrière, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 110 | |
| 2 | 2014 | 118 | |
| 3 | 2013 | 23 | |
| 4 | 2012 | 84 | |
| 5 | Mesenchymal characterization: alternative to simple CTC detection in two clinical trials. | 2012 | 27 |
| 6 | 2012 | 47 | |
| 7 | 2011 | 32 | |
| 8 | 2007 | 31 | |
| 9 | 2005 | 3 | |
| 10 | 2005 | 35 | |
| 11 | PHGPx overexpression induces an increase in COX-2 activity in colon carcinoma cells. | 2004 | 5 |
| 12 | 2003 | 27 | |
| 13 | 1958 | 0 |
About Guislaine Barrière
Guislaine Barrière is a scholar working on Toxicology, Oncology, Nephrology, Biochemistry and Cancer Research, having authored 13 papers that have together received 542 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Metastasis and carcinoma case studies (4 papers), Cancer Diagnosis and Treatment (2 papers), Cancer Genomics and Diagnostics (1 paper), Selenium in Biological Systems (1 paper), Cell death mechanisms and regulation (1 paper), Estrogen and related hormone effects (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Cancer Research (211 citations), Oncology (301 citations), Pulmonary and Respiratory Medicine (102 citations), Molecular Biology (193 citations) and Biological Psychiatry (6 citations). Guislaine Barrière has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include Michel Rigaud, Pietro Fici, Giulia Gallerani, Francesco� Fabbri, Wainer Zoli, Jeanne Cook‐Moreau, Karine Faucher, Franck Sturtz, Fernand Boutros-Toni and F Tabaraud. Their work appears in journals such as Biochimie, Immunology, BMC Cancer, Anti-Cancer Agents in Medicinal Chemistry and Acta Neurologica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.